Elekta (OTCMKTS:EKTAY) Shares Gap Down – Should You Sell?

Elekta AB (OTCMKTS:EKTAY) shares gapped down before the market opened on Wednesday . The stock had previously closed at $5.5599, but opened at $5.00. Elekta shares last traded at $5.00, with a volume of 2,722 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered Elekta from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

Elekta Price Performance

The company has a current ratio of 0.95, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56. The company has a market cap of $1.86 billion, a PE ratio of -31.50 and a beta of 1.00. The firm has a 50 day moving average of $5.94 and a two-hundred day moving average of $6.08.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. The company had revenue of $521.00 million for the quarter. Elekta had a positive return on equity of 10.67% and a negative net margin of 3.32%. Research analysts predict that Elekta AB will post 0.43 earnings per share for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.